InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ARS Pharmaceuticals, Inc.

SPRY Clue Score36
United States Fiscal year ends December CIK 0001671858 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

250
Insider
Date
Role
Action
Shares
Price
Amount
Alexander A Fitzpatrick
12 Jun 2026
Chief Legal Officer
Sold on a plan
3,355
$10.00
$33.55K
Eric Karas
12 Jun 2026
Chief Commercial Officer
Sold after exercise
25,000
$10.00
$250.00K
Brian Dorsey
13 Nov 2025
Chief Operating Officer
Sold after exercise
21,828
$8.71
$190.05K
Justin Chakma
12 Nov 2025
Chief Business Officer
Sold after exercise
136,380
$8.86
$1.21M
Justin Chakma
12 Nov 2025
Chief Business Officer
Sold after exercise
30,000
$8.91
$267.36K
Kathleen D. Scott
21 Aug 2025
Chief Financial Officer
Sold after exercise
12,500
$15.00
$187.50K
Richard E Lowenthal
21 Aug 2025
President and CEO
Sold on a plan indirect
50,000
$14.49
$724.35K
Sarina Tanimoto
20 Aug 2025
Chief Medical Officer
Sold on a plan indirect
37,656
$14.09
$530.63K
Sarina Tanimoto
19 Aug 2025
Chief Medical Officer
Sold on a plan indirect
12,344
$14.03
$173.13K
Eric Karas
1 Jul 2025
Chief Commercial Officer
Sold after exercise
15,000
$16.99
$254.86K
James E Flynn
27 Jun 2025
10% owner
Sell indirect
370,074
$18.46
$6.83M
James E Flynn
27 Jun 2025
10% owner
Sell indirect
370,075
$18.46
$6.83M
Eric Karas
18 Jun 2025
Chief Commercial Officer
Sold after exercise
15,000
$16.00
$240.00K
Kathleen D. Scott
20 May 2025
Chief Financial Officer
Sold after exercise
50,000
$14.10
$705.17K
Brent L Saunders
20 May 2025
Director
Sold after exercise
120,000
$14.25
$1.71M
Alexander A Fitzpatrick
20 May 2025
Chief Legal Officer
Sold after exercise
102,969
$14.10
$1.45M
Laura Shawver
7 Apr 2025
Director
Sold after exercise
50,002
$12.30
$615.07K
Eric Karas
20 Mar 2025
Chief Commercial Officer
Sold after exercise
10,000
$14.00
$140.00K
Laura Shawver
6 Mar 2025
Director
Sold after exercise
49,600
$11.21
$556.05K
Laura Shawver
5 Mar 2025
Director
Sold after exercise
400
$11.00
$4.40K
Laura Shawver
3 Feb 2025
Director
Sold after exercise
50,000
$12.31
$615.57K
Laura Shawver
6 Jan 2025
Director
Sold after exercise
50,000
$11.10
$555.07K
Richard E Lowenthal
17 Dec 2024
President and CEO
Sold on a plan indirect
50,000
$11.67
$583.53K
Richard E Lowenthal
17 Dec 2024
President and CEO
Sold on a plan indirect
50,000
$11.67
$583.58K
Sarina Tanimoto
17 Dec 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$11.67
$583.53K
Sarina Tanimoto
17 Dec 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$11.67
$583.58K
Justin Chakma
13 Dec 2024
Chief Business Officer
Sold after exercise
27,272
$12.06
$328.97K
Brian Dorsey
12 Dec 2024
Chief Operating Officer
Sold after exercise
25,000
$12.30
$307.43K
Justin Chakma
12 Dec 2024
Chief Business Officer
Sold after exercise
117,333
$12.27
$1.44M
Brian Dorsey
11 Dec 2024
Chief Operating Officer
Sold after exercise
15,000
$12.43
$186.43K
Richard E Lowenthal
10 Dec 2024
President and CEO
Sold on a plan indirect
50,000
$13.16
$658.16K
Richard E Lowenthal
10 Dec 2024
President and CEO
Sold on a plan indirect
50,000
$13.17
$658.27K
Sarina Tanimoto
10 Dec 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$13.16
$658.16K
Sarina Tanimoto
10 Dec 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$13.17
$658.27K
Justin Chakma
10 Dec 2024
Chief Business Officer
Sold after exercise
50,000
$13.15
$657.63K
Justin Chakma
6 Dec 2024
Chief Business Officer
Sold after exercise
50,000
$14.23
$711.62K
Richard E Lowenthal
6 Dec 2024
President and CEO
Exercised, kept indirect
11,876
$8.42
$100.00K
Richard E Lowenthal
6 Dec 2024
President and CEO
Exercised, kept indirect
13,789
$1.44
$19.86K
Richard E Lowenthal
6 Dec 2024
President and CEO
Exercised, kept
11,876
$8.42
$100.00K
Sarina Tanimoto
6 Dec 2024
Chief Medical Officer
Exercised, kept indirect
11,876
$8.42
$100.00K
Sarina Tanimoto
6 Dec 2024
Chief Medical Officer
Exercised, kept
11,876
$8.42
$100.00K
Sarina Tanimoto
6 Dec 2024
Chief Medical Officer
Exercised, kept
13,789
$1.44
$19.86K
Justin Chakma
5 Dec 2024
Chief Business Officer
Sold after exercise
49,640
$14.13
$701.64K
Eric Karas
4 Dec 2024
Chief Commercial Officer
Sold after exercise
6,283
$14.00
$87.96K
Laura Shawver
4 Dec 2024
Director
Sold after exercise
14,772
$13.75
$203.11K
Justin Chakma
4 Dec 2024
Chief Business Officer
Sold after exercise
45,000
$13.95
$627.94K
Laura Shawver
3 Dec 2024
Director
Sold after exercise
87,984
$13.26
$1.17M
Justin Chakma
3 Dec 2024
Chief Business Officer
Sold after exercise
45,000
$13.19
$593.40K
Eric Karas
2 Dec 2024
Chief Commercial Officer
Sold after exercise
3,717
$14.11
$52.46K
Laura Shawver
2 Dec 2024
Director
Sold after exercise
901
$14.34
$12.92K
Laura Shawver
2 Dec 2024
Director
Sold after exercise
96,343
$13.55
$1.31M
Justin Chakma
2 Dec 2024
Chief Business Officer
Sold after exercise
45,000
$13.67
$615.22K
Justin Chakma
27 Nov 2024
Chief Business Officer
Sell
25,000
$14.39
$359.75K
Justin Chakma
26 Nov 2024
Chief Business Officer
Sell
42,186
$14.05
$592.57K
Justin Chakma
25 Nov 2024
Chief Business Officer
Sell
32,814
$14.00
$459.42K
Sarina Tanimoto
19 Nov 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$13.95
$697.45K
Sarina Tanimoto
19 Nov 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$13.95
$697.51K
Richard E Lowenthal
19 Nov 2024
President and CEO
Sold on a plan indirect
50,000
$13.95
$697.45K
Richard E Lowenthal
19 Nov 2024
President and CEO
Sold on a plan indirect
50,000
$13.95
$697.51K
James E Flynn
12 Nov 2024
10% owner
Sell indirect
9,553
$17.77
$169.76K
James E Flynn
12 Nov 2024
10% owner
Sell indirect
9,554
$17.77
$169.77K
James E Flynn
12 Nov 2024
10% owner
Sell indirect
7,854
$17.16
$134.77K
James E Flynn
12 Nov 2024
10% owner
Sell indirect
7,853
$17.16
$134.76K
Richard E Lowenthal
12 Nov 2024
President and CEO
Sold on a plan indirect
4,876
$17.64
$86.02K
Richard E Lowenthal
12 Nov 2024
President and CEO
Sold on a plan indirect
45,124
$16.76
$756.30K
Richard E Lowenthal
12 Nov 2024
President and CEO
Sold on a plan indirect
4,955
$17.64
$87.42K
Richard E Lowenthal
12 Nov 2024
President and CEO
Sold on a plan indirect
45,045
$16.76
$754.90K
Sarina Tanimoto
12 Nov 2024
Chief Medical Officer
Sold on a plan indirect
4,876
$17.64
$86.02K
Sarina Tanimoto
12 Nov 2024
Chief Medical Officer
Sold on a plan indirect
45,124
$16.76
$756.30K
Sarina Tanimoto
12 Nov 2024
Chief Medical Officer
Sold on a plan indirect
4,955
$17.64
$87.42K
Sarina Tanimoto
12 Nov 2024
Chief Medical Officer
Sold on a plan indirect
45,045
$16.76
$754.90K
James E Flynn
11 Nov 2024
10% owner
Sell indirect
223,632
$18.15
$4.06M
James E Flynn
11 Nov 2024
10% owner
Sell indirect
223,632
$18.15
$4.06M
James E Flynn
11 Nov 2024
10% owner
Sell indirect
40,596
$17.45
$708.40K
James E Flynn
11 Nov 2024
10% owner
Sell indirect
40,596
$17.45
$708.40K
Kathleen D. Scott
16 Oct 2024
Chief Financial Officer
Sold after exercise
12,500
$16.00
$200.00K
Richard E Lowenthal
15 Oct 2024
President and CEO
Sold on a plan indirect
50,000
$14.88
$743.82K
Richard E Lowenthal
15 Oct 2024
President and CEO
Sold on a plan indirect
1,450
$15.25
$22.12K
Richard E Lowenthal
15 Oct 2024
President and CEO
Sold on a plan indirect
48,550
$14.86
$721.66K
Sarina Tanimoto
15 Oct 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$14.88
$743.82K
Sarina Tanimoto
15 Oct 2024
Chief Medical Officer
Sold on a plan indirect
1,450
$15.25
$22.12K
Sarina Tanimoto
15 Oct 2024
Chief Medical Officer
Sold on a plan indirect
48,550
$14.86
$721.66K
Richard E Lowenthal
8 Oct 2024
President and CEO
Sold on a plan indirect
50,000
$13.83
$691.39K
Richard E Lowenthal
8 Oct 2024
President and CEO
Sold on a plan indirect
50,000
$13.83
$691.39K
Sarina Tanimoto
8 Oct 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$13.83
$691.39K
Sarina Tanimoto
8 Oct 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$13.83
$691.39K
Eric Karas
18 Sep 2024
Chief Commercial Officer
Sold after exercise
10,000
$14.00
$140.00K
Richard E Lowenthal
17 Sep 2024
President and CEO
Sold on a plan indirect
50,000
$12.93
$646.68K
Richard E Lowenthal
17 Sep 2024
President and CEO
Sold on a plan indirect
50,000
$12.93
$646.53K
Sarina Tanimoto
17 Sep 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$12.93
$646.68K
Sarina Tanimoto
17 Sep 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$12.93
$646.53K
Richard E Lowenthal
10 Sep 2024
President and CEO
Sold on a plan indirect
50,000
$11.50
$574.91K
Richard E Lowenthal
10 Sep 2024
President and CEO
Sold on a plan indirect
50,000
$11.50
$574.87K
Sarina Tanimoto
10 Sep 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$11.50
$574.91K
Sarina Tanimoto
10 Sep 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$11.50
$574.87K
Orbimed Advisors LLC
26 Aug 2024
Director
Sell indirect
83,695
$13.00
$1.09M
Peter A. Thompson
26 Aug 2024
Director
Sell indirect
83,695
$13.00
$1.09M
Orbimed Advisors LLC
23 Aug 2024
Director
Sell indirect
69,500
$13.03
$905.59K
Peter A. Thompson
23 Aug 2024
Director
Sell indirect
69,500
$13.03
$905.59K
Orbimed Advisors LLC
22 Aug 2024
Director
Sell indirect
391,482
$12.94
$5.07M
Peter A. Thompson
22 Aug 2024
Director
Sell indirect
391,482
$12.94
$5.07M
Orbimed Advisors LLC
21 Aug 2024
Director
Sell indirect
13,300
$14.61
$194.31K
Orbimed Advisors LLC
21 Aug 2024
Director
Sell indirect
394,400
$13.52
$5.33M
Peter A. Thompson
21 Aug 2024
Director
Sell indirect
13,300
$14.61
$194.31K
Peter A. Thompson
21 Aug 2024
Director
Sell indirect
394,400
$13.52
$5.33M
Richard E Lowenthal
20 Aug 2024
President and CEO
Sold on a plan indirect
2,261
$16.25
$36.75K
Richard E Lowenthal
20 Aug 2024
President and CEO
Sold on a plan indirect
11,523
$15.62
$180.03K
Richard E Lowenthal
20 Aug 2024
President and CEO
Sold on a plan indirect
36,216
$14.76
$534.46K
Richard E Lowenthal
20 Aug 2024
President and CEO
Sold on a plan indirect
2,300
$16.26
$37.40K
Richard E Lowenthal
20 Aug 2024
President and CEO
Sold on a plan indirect
11,756
$15.61
$183.55K
Richard E Lowenthal
20 Aug 2024
President and CEO
Sold on a plan indirect
35,944
$14.76
$530.41K
Sarina Tanimoto
20 Aug 2024
Chief Medical Officer
Sold on a plan indirect
2,261
$16.25
$36.75K
Sarina Tanimoto
20 Aug 2024
Chief Medical Officer
Sold on a plan indirect
11,523
$15.62
$180.03K
Sarina Tanimoto
20 Aug 2024
Chief Medical Officer
Sold on a plan indirect
36,216
$14.76
$534.46K
Sarina Tanimoto
20 Aug 2024
Chief Medical Officer
Sold on a plan indirect
2,300
$16.26
$37.40K
Sarina Tanimoto
20 Aug 2024
Chief Medical Officer
Sold on a plan indirect
11,756
$15.61
$183.55K
Sarina Tanimoto
20 Aug 2024
Chief Medical Officer
Sold on a plan indirect
35,944
$14.76
$530.41K
Kathleen D. Scott
20 Aug 2024
Chief Financial Officer
Sold after exercise
12,500
$16.00
$200.00K
Brian Dorsey
20 Aug 2024
Chief Operating Officer
Sold after exercise
50,000
$15.00
$750.00K
Eric Karas
19 Aug 2024
Chief Commercial Officer
Sold after exercise
10,000
$14.00
$140.00K
Richard E Lowenthal
13 Aug 2024
President and CEO
Sold on a plan indirect
35,363
$12.77
$451.44K
Richard E Lowenthal
13 Aug 2024
President and CEO
Sold on a plan indirect
14,637
$11.77
$172.33K
Richard E Lowenthal
13 Aug 2024
President and CEO
Sold on a plan indirect
35,401
$12.76
$451.88K
Richard E Lowenthal
13 Aug 2024
President and CEO
Sold on a plan indirect
14,599
$11.78
$171.91K
Sarina Tanimoto
13 Aug 2024
Chief Medical Officer
Sold on a plan indirect
35,363
$12.77
$451.44K
Sarina Tanimoto
13 Aug 2024
Chief Medical Officer
Sold on a plan indirect
14,637
$11.77
$172.33K
Sarina Tanimoto
13 Aug 2024
Chief Medical Officer
Sold on a plan indirect
35,401
$12.76
$451.88K
Sarina Tanimoto
13 Aug 2024
Chief Medical Officer
Sold on a plan indirect
14,599
$11.78
$171.91K
Brian Dorsey
13 Aug 2024
Chief Operating Officer
Sold after exercise
30,000
$13.00
$390.00K
Sarina Tanimoto
16 Jul 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$11.40
$570.16K
Sarina Tanimoto
16 Jul 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$11.40
$570.14K
Richard E Lowenthal
16 Jul 2024
President and CEO
Sold on a plan indirect
50,000
$11.40
$570.16K
Richard E Lowenthal
16 Jul 2024
President and CEO
Sold on a plan indirect
50,000
$11.40
$570.14K
Richard E Lowenthal
9 Jul 2024
President and CEO
Sold on a plan indirect
50,000
$9.62
$480.84K
Richard E Lowenthal
9 Jul 2024
President and CEO
Sold on a plan indirect
50,000
$9.62
$480.89K
Sarina Tanimoto
9 Jul 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$9.62
$480.84K
Sarina Tanimoto
9 Jul 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$9.62
$480.89K
Sarina Tanimoto
12 Jun 2024
Chief Medical Officer
Sold on a plan indirect
48,028
$9.14
$439.20K
Sarina Tanimoto
12 Jun 2024
Chief Medical Officer
Sold on a plan indirect
47,834
$9.15
$437.46K
Richard E Lowenthal
12 Jun 2024
President and CEO
Sold on a plan indirect
48,028
$9.14
$439.20K
Richard E Lowenthal
12 Jun 2024
President and CEO
Sold on a plan indirect
47,834
$9.15
$437.46K
Sarina Tanimoto
11 Jun 2024
Chief Medical Officer
Sold on a plan indirect
1,972
$9.00
$17.76K
Sarina Tanimoto
11 Jun 2024
Chief Medical Officer
Sold on a plan indirect
2,166
$9.00
$19.50K
Richard E Lowenthal
11 Jun 2024
President and CEO
Sold on a plan indirect
1,972
$9.00
$17.76K
Richard E Lowenthal
11 Jun 2024
President and CEO
Sold on a plan indirect
2,166
$9.00
$19.50K
Richard E Lowenthal
16 May 2024
President and CEO
Sold on a plan indirect
44,350
$9.06
$401.71K
Richard E Lowenthal
16 May 2024
President and CEO
Sold on a plan indirect
44,746
$9.06
$405.31K
Sarina Tanimoto
16 May 2024
Chief Medical Officer
Sold on a plan indirect
44,350
$9.06
$401.71K
Sarina Tanimoto
16 May 2024
Chief Medical Officer
Sold on a plan indirect
44,746
$9.06
$405.31K
Richard E Lowenthal
15 May 2024
President and CEO
Sold on a plan indirect
2,766
$9.04
$25.01K
Richard E Lowenthal
15 May 2024
President and CEO
Sold on a plan indirect
2,381
$9.05
$21.56K
Sarina Tanimoto
15 May 2024
Chief Medical Officer
Sold on a plan indirect
2,766
$9.04
$25.01K
Sarina Tanimoto
15 May 2024
Chief Medical Officer
Sold on a plan indirect
2,381
$9.05
$21.56K
Richard E Lowenthal
14 May 2024
President and CEO
Sold on a plan indirect
2,884
$9.01
$25.97K
Richard E Lowenthal
14 May 2024
President and CEO
Sold on a plan indirect
2,873
$9.01
$25.88K
Sarina Tanimoto
14 May 2024
Chief Medical Officer
Sold on a plan indirect
2,884
$9.01
$25.97K
Sarina Tanimoto
14 May 2024
Chief Medical Officer
Sold on a plan indirect
2,873
$9.01
$25.88K
Richard E Lowenthal
7 May 2024
President and CEO
Sold on a plan indirect
50,000
$9.34
$467.23K
Richard E Lowenthal
7 May 2024
President and CEO
Sold on a plan indirect
50,000
$9.34
$467.14K
Sarina Tanimoto
7 May 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$9.34
$467.23K
Sarina Tanimoto
7 May 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$9.34
$467.14K
Richard E Lowenthal
23 Apr 2024
President and CEO
Exercised, kept indirect
48,260
$1.44
$69.49K
Richard E Lowenthal
23 Apr 2024
President and CEO
Exercised, kept indirect
82,733
$0.84
$69.50K
Sarina Tanimoto
23 Apr 2024
Chief Medical Officer
Exercised, kept
48,260
$1.44
$69.49K
Sarina Tanimoto
23 Apr 2024
Chief Medical Officer
Exercised, kept
82,733
$0.84
$69.50K
Richard E Lowenthal
19 Apr 2024
President and CEO
Exercised, kept
69,444
$1.44
$100.00K
Richard E Lowenthal
19 Apr 2024
President and CEO
Exercised, kept
119,047
$0.84
$100.00K
Sarina Tanimoto
19 Apr 2024
Chief Medical Officer
Exercised, kept indirect
69,444
$1.44
$100.00K
Sarina Tanimoto
19 Apr 2024
Chief Medical Officer
Exercised, kept indirect
119,047
$0.84
$100.00K
Richard E Lowenthal
16 Apr 2024
President and CEO
Sold on a plan indirect
50,000
$9.28
$463.99K
Richard E Lowenthal
16 Apr 2024
President and CEO
Sold on a plan indirect
50,000
$9.28
$464.02K
Sarina Tanimoto
16 Apr 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$9.28
$463.99K
Sarina Tanimoto
16 Apr 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$9.28
$464.02K
Richard E Lowenthal
9 Apr 2024
President and CEO
Sold on a plan indirect
50,000
$9.28
$463.85K
Richard E Lowenthal
9 Apr 2024
President and CEO
Sold on a plan indirect
50,000
$9.28
$463.89K
Sarina Tanimoto
9 Apr 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$9.28
$463.85K
Sarina Tanimoto
9 Apr 2024
Chief Medical Officer
Sold on a plan indirect
50,000
$9.28
$463.89K
Ra Capital Management, L.p.
27 Mar 2024
Director
Buy indirect
505,954
$9.79
$4.95M
Ra Capital Management, L.p.
26 Mar 2024
Director
Buy indirect
457,745
$9.55
$4.37M
Sarina Tanimoto
25 Mar 2024
Chief Medical Officer
Sold on a plan indirect
47,632
$9.12
$434.58K
Sarina Tanimoto
25 Mar 2024
Chief Medical Officer
Sold on a plan indirect
47,635
$9.12
$434.61K
Richard E Lowenthal
25 Mar 2024
President and CEO
Sold on a plan indirect
47,632
$9.12
$434.58K
Richard E Lowenthal
25 Mar 2024
President and CEO
Sold on a plan indirect
47,635
$9.12
$434.61K
Ra Capital Management, L.p.
25 Mar 2024
Director
Buy indirect
437,600
$9.06
$3.96M
Sarina Tanimoto
22 Mar 2024
Chief Medical Officer
Sold on a plan indirect
1,326
$9.01
$11.95K
Sarina Tanimoto
22 Mar 2024
Chief Medical Officer
Sold on a plan indirect
1,017
$9.03
$9.18K
Richard E Lowenthal
22 Mar 2024
President and CEO
Sold on a plan indirect
1,326
$9.01
$11.95K
Richard E Lowenthal
22 Mar 2024
President and CEO
Sold on a plan indirect
1,017
$9.03
$9.18K
Sarina Tanimoto
21 Mar 2024
Chief Medical Officer
Sold on a plan indirect
100
$9.00
$900.00
Sarina Tanimoto
21 Mar 2024
Chief Medical Officer
Sold on a plan indirect
372
$9.00
$3.35K
Richard E Lowenthal
21 Mar 2024
President and CEO
Sold on a plan indirect
100
$9.00
$900.00
Richard E Lowenthal
21 Mar 2024
President and CEO
Sold on a plan indirect
372
$9.00
$3.35K
Sarina Tanimoto
19 Mar 2024
Chief Medical Officer
Sold on a plan indirect
942
$9.04
$8.51K
Sarina Tanimoto
19 Mar 2024
Chief Medical Officer
Sold on a plan indirect
976
$9.03
$8.81K
Richard E Lowenthal
19 Mar 2024
President and CEO
Sold on a plan indirect
942
$9.04
$8.51K
Richard E Lowenthal
19 Mar 2024
President and CEO
Sold on a plan indirect
976
$9.03
$8.81K
Sarina Tanimoto
15 Mar 2024
Chief Medical Officer
Sold on a plan indirect
48,461
$9.14
$443.00K
Sarina Tanimoto
15 Mar 2024
Chief Medical Officer
Sold on a plan indirect
48,295
$9.14
$441.49K
Richard E Lowenthal
15 Mar 2024
President and CEO
Sold on a plan indirect
48,461
$9.14
$443.00K
Richard E Lowenthal
15 Mar 2024
President and CEO
Sold on a plan indirect
48,295
$9.14
$441.49K
Sarina Tanimoto
14 Mar 2024
Chief Medical Officer
Sold on a plan indirect
239
$9.00
$2.15K
Sarina Tanimoto
14 Mar 2024
Chief Medical Officer
Sold on a plan indirect
205
$9.00
$1.85K
Richard E Lowenthal
14 Mar 2024
President and CEO
Sold on a plan indirect
239
$9.00
$2.15K
Richard E Lowenthal
14 Mar 2024
President and CEO
Sold on a plan indirect
205
$9.00
$1.85K
Sarina Tanimoto
13 Mar 2024
Chief Medical Officer
Sold on a plan indirect
1,300
$9.00
$11.70K
Sarina Tanimoto
13 Mar 2024
Chief Medical Officer
Sold on a plan indirect
1,500
$9.00
$13.50K
Richard E Lowenthal
13 Mar 2024
President and CEO
Sold on a plan indirect
1,300
$9.00
$11.70K
Richard E Lowenthal
13 Mar 2024
President and CEO
Sold on a plan indirect
1,500
$9.00
$13.50K
Richard E Lowenthal
29 Feb 2024
President and CEO
Sold on a plan indirect
1,000
$9.02
$9.02K
Richard E Lowenthal
29 Feb 2024
President and CEO
Sold on a plan indirect
1,982
$9.01
$17.87K
Richard E Lowenthal
29 Feb 2024
President and CEO
Sold on a plan indirect
800
$9.02
$7.22K
Sarina Tanimoto
29 Feb 2024
Chief Medical Officer
Sold on a plan indirect
1,000
$9.02
$9.02K
Sarina Tanimoto
29 Feb 2024
Chief Medical Officer
Sold on a plan indirect
1,982
$9.01
$17.87K
Sarina Tanimoto
29 Feb 2024
Chief Medical Officer
Sold on a plan indirect
800
$9.02
$7.22K
Richard E Lowenthal
28 Feb 2024
President and CEO
Sold on a plan indirect
24,303
$9.02
$219.23K
Richard E Lowenthal
28 Feb 2024
President and CEO
Sold on a plan indirect
49,019
$9.02
$442.21K
Richard E Lowenthal
28 Feb 2024
President and CEO
Sold on a plan indirect
25,456
$9.02
$229.63K
Sarina Tanimoto
28 Feb 2024
Chief Medical Officer
Sold on a plan indirect
24,303
$9.02
$219.23K
Sarina Tanimoto
28 Feb 2024
Chief Medical Officer
Sold on a plan indirect
49,019
$9.02
$442.21K
Sarina Tanimoto
28 Feb 2024
Chief Medical Officer
Sold on a plan indirect
25,456
$9.02
$229.63K
Richard E Lowenthal
26 Feb 2024
President and CEO
Sold on a plan indirect
100
$9.01
$901.00
Richard E Lowenthal
26 Feb 2024
President and CEO
Sold on a plan indirect
500
$9.01
$4.51K
Richard E Lowenthal
26 Feb 2024
President and CEO
Sold on a plan indirect
100
$9.01
$901.00
Sarina Tanimoto
26 Feb 2024
Chief Medical Officer
Sold on a plan indirect
100
$9.01
$901.00
Sarina Tanimoto
26 Feb 2024
Chief Medical Officer
Sold on a plan indirect
500
$9.01
$4.51K
Sarina Tanimoto
26 Feb 2024
Chief Medical Officer
Sold on a plan indirect
100
$9.01
$901.00
Alexander A Fitzpatrick
29 Sep 2023
Chief Legal Officer
Buy
46,258
$3.78
$174.99K
Alexander A Fitzpatrick
28 Sep 2023
Chief Legal Officer
Buy
40,000
$3.62
$144.96K
Ra Capital Management, L.p.
21 Sep 2023
Director
Buy indirect
191,309
$3.83
$732.71K
Ra Capital Management, L.p.
21 Sep 2023
Director
Buy indirect
2,508,691
$2.97
$7.45M
Laura Shawver
1 Sep 2023
Director
Sold after exercise
100,000
$7.71
$770.52K
Peter A. Thompson
29 Aug 2023
Director
Buy indirect
500,000
$6.20
$3.10M
Orbimed Advisors LLC
29 Aug 2023
Director
Buy indirect
500,000
$6.20
$3.10M
Ra Capital Management, L.p.
29 Aug 2023
Director
Buy indirect
3,750,000
$6.20
$23.25M
Laura Shawver
4 Aug 2023
Director
Sold after exercise
18,897
$7.06
$133.47K
Laura Shawver
3 Aug 2023
Director
Sold after exercise
26,107
$7.01
$183.02K
Laura Shawver
2 Aug 2023
Director
Sold after exercise
36,281
$7.09
$257.26K
Laura Shawver
1 Aug 2023
Director
Sold after exercise
18,715
$7.19
$134.58K
Laura Shawver
7 Jul 2023
Director
Sold after exercise
8,858
$6.36
$56.37K
Laura Shawver
6 Jul 2023
Director
Sold after exercise
33,510
$6.34
$212.55K
Laura Shawver
5 Jul 2023
Director
Sold after exercise
31,112
$6.41
$199.55K
Laura Shawver
3 Jul 2023
Director
Sold after exercise
26,520
$6.73
$178.35K
Laura Shawver
2 Jun 2023
Director
Sold after exercise
26,941
$6.95
$187.24K
Laura Shawver
1 Jun 2023
Director
Sold after exercise
73,059
$6.80
$496.80K
Laura Shawver
9 May 2023
Director
Sold after exercise
42,900
$5.31
$227.80K
Laura Shawver
8 May 2023
Director
Sold after exercise
57,100
$6.16
$351.74K
Kathleen D. Scott
29 Nov 2022
Chief Financial Officer
Buy indirect
8,250
$6.24
$51.51K
Laura Shawver
9 Nov 2022
Director
Sold on a plan
43,896
$4.58
$201.04K
Laura Shawver
5 Aug 2022
Chief Executive Officer
Exercised, kept
78,740
$1.27
$100.00K
Jonathan D Root
15 Nov 2021
Director
Buy indirect
2,014
$8.85
$17.82K
Showing 250 of 261 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 231
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 149
Sales straight out of an exercise 51
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 84,407,624
History held since 7 Dec 2020